Fiber-optic drug delivery strategy for synergistic cancer photothermal-chemotherapy

Yongkang Zhang; Jie Zheng; Fangzhou Jin; Jie Xiao; Ni Lan; Zhiyuan Xu; Xu Yue; Zesen Li; Chengzhi Li; Donglin Cao; Yifei Wang; Wenbin Zhong; Yang Ran; Bai-Ou Guan

doi:10.1038/s41377-024-01586-z

Go to Nature Website

Your Location：

Home >

Browse articles >

Fiber-optic drug delivery strategy for synergistic cancer photothermal-chemotherapy

Original Articles

- Fiber-optic drug delivery strategy for synergistic cancer photothermal-chemotherapy
- Light: Science & Applications Vol. 13, Issue 10, Pages: 2389-2404(2024)
- Affiliations：
  
  1.Guangdong Provincial Key Laboratory of Optical Fiber Sensing and Communications, Institute of Photonics Technology, Jinan University, Guangzhou, China
  2.College of Physics & Optoelectronic Engineering, Jinan University, Guangzhou, China
  3.The MOE Key Laboratory of Tumor Molecular Biology, Jinan University, Guangzhou, China
  4.Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou, China
  5.Department of Laboratory Medicine, the Affiliated Guangdong Second Provincial General Hospital of Jinan University, Guangzhou, China
  6.Department of Interventional Radiology and Vascular Surgery, The First Affiliated Hospital of Jinan University, Jinan University, Guangzhou, China
- Author bio：
  
  Yang Ran (tranyang@jnu.edu.cn)
  Bai-Ou Guan (tguanbo@jnu.edu.cn)
- Funds：
- DOI：10.1038/s41377-024-01586-z
  CLC：
- Published：31 October 2024，
  
  Published Online：03 September 2024，
  
  Received：02 March 2024，
  
  Revised：28 July 2024，
  
  Accepted：14 August 2024
- Accepted：
Scan QR Code
Zhang, Y. K. et al. Fiber-optic drug delivery strategy for synergistic cancer photothermal-chemotherapy. Light: Science & Applications, 13, 2389-2404 (2024).
DOI：

Zhang, Y. K. et al. Fiber-optic drug delivery strategy for synergistic cancer photothermal-chemotherapy. Light: Science & Applications, 13, 2389-2404 (2024). DOI： 10.1038/s41377-024-01586-z.

摘要

Abstract

Chemotherapy is one of the conventional treatments for cancer in clinical practice. However

poor delivery efficiency

systemic toxicity

and the lack of pharmacokinetic monitoring during treatment are the critical limitations of current chemotherapy. Herein

we reported a brand-new antitumor drug delivery strategy that harnesses an optical fiber endoscopically therapeutic probe. The fiber probe carries photosensitizers in the fiber core and antitumor agents on the fiber surface mediated by a temperature-responsive hydrogel film

giving rise to an activable photothermal-chemotherapy that orchestrates the localized hyperthermia and thermal-stimuli drug release to the tumor lesion. Furthermore

the dynamical drug release and in-situ temperature can be real-time supervised through the built-in fiber sensors

including the reflective Mach–Zehnder interferometer and fiber Bragg grating

to visualize the therapy process and thus improve the safety of treatment. Compared with conventional methods

the fiber-optic drug delivery can adequately take advantage of the chemotherapeutics through collaboratively recruiting the photoheating-mediated enhanced permeability and the hydrogel particle-assisted high drug retention

shedding new light on a "central-to-peripheral" drug pervasion and retention mechanism to destroy tumors completely. The fiber-optic chemotherapy strategy incorporates precise drug delivery

accurate controllability of drug release

high drug permeability and retention in tumor

low off-target rate

and real-time drug release and temperature feedback

performing a straightforward and precise photothermal-chemotherapy pathway. More than that

the proposed strategy holds tremendous promise to provide a revolutionized on-demand drug delivery platform for the highly efficient evaluation and screening of antitumor pharmaceuticals.

关键词

Keywords

references

Chhikara, B. S.&Parang, K. Global cancer statistics 2022: the trends projection analysis.Chem. Biol. Lett.10, 451 (2023)..

Williams, P. A., Zaidi, S. K.&Sengupta, R. AACR cancer progress report 2022: decoding cancer complexity, integrating science, and transforming patient outcomes.Clin. Cancer Res.28, 4178–4179 (2022)..

Bhatia, S. N. et al. Cancer nanomedicine.Nat. Rev. Cancer22, 550–556 (2022)..

Jain, R. K.&Stylianopoulos, T. Delivering nanomedicine to solid tumors.Nat. Rev. Clin. Oncol.7, 653–664 (2010)..

Kim, S. M., Faix, P. H.&Schnitzer, J. E. Overcoming key biological barriers to cancer drug delivery and efficacy.J. Control. Release267, 15–30 (2017)..

Cavaletti, G. Peripheral neurotoxicity of platinum-based chemotherapy.Nat. Rev. Cancer8, 72–72 (2008)..

Li, Z., Zou, J. H.&Chen, X. Y. In response to precision medicine: current subcellular targeting strategies for cancer therapy.Adv. Mater.35, 2209529 (2023)..

Senapati, S. et al. Controlled drug delivery vehicles for cancer treatment and their performance.Signal Transduct. Target. Ther.3, 7 (2018)..

Wang, Y. F.&Kohane, D. S. External triggering and triggered targeting strategies for drug delivery.Nat. Rev. Mater.2, 17020 (2017)..

Li, X. S. et al. Clinical development and potential of photothermal and photodynamic therapies for cancer.Nat. Rev. Clin. Oncol.17, 657–674 (2020)..

Liu, Y. J. et al. Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer.Chem. Soc. Rev.48, 2053–2108 (2019)..

van der Meel, R. et al. Smart cancer nanomedicine.Nat. Nanotechnol.14, 1007–1017 (2019)..

Dunne, M., Regenold, M.&Allen, C. Hyperthermia can alter tumor physiology and improve chemo- andradio-therapy efficacy.Adv. Drug Deliv. Rev.163-164, 98–124 (2020)..

Phung, D. C. et al. Combined hyperthermia and chemotherapy as a synergistic anticancer treatment.J. Pharm. Investig.49, 519–526 (2019)..

Ribeiro, T. P. et al. Nanomaterials in cancer: reviewing the combination of hyperthermia and triggered chemotherapy.J. Control. Release347, 89–103 (2022)..

Cheng, D. B. et al. Intracellular self-immolative polyprodrug with near-infrared light guided accumulation and in vivo visualization of drug release.Adv. Mater.34, 2109528 (2022)..

Chen, W. et al. Smart chemical engineering-based lightweight and miniaturized attachable systems for advanced drug delivery and diagnostics.Adv. Mater.34, 2106701 (2022)..

Wang, R. et al. In vivo gastrointestinal drug-release monitoring through second near-infrared window fluorescent bioimaging with orally delivered microcarriers.Nat. Commun.8, 14702 (2017)..

Pang, Q. et al. Smart flexible electronics-integrated wound dressing for real-time monitoring and on-demand treatment of infected wounds.Adv. Sci.7, 1902673 (2020)..

Yong, T. Y. et al. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy.Nat. Commun.10, 3838 (2019)..

Yang, K. K. et al. Supramolecular polymerization-induced nanoassemblies for self-augmented cascade chemotherapy and chemodynamic therapy of tumor.Angew. Chem. Int. Ed.60, 17570–17578 (2021)..

Tan, A. R. et al. Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study.Lancet Oncol.22, 85–97 (2021)..

Zhao, P. F. et al. NIR-driven smart theranostic nanomedicine for on-demand drug release and synergistic antitumour therapy.Sci. Rep.5, 14258 (2015)..

Chin, A. L. et al. Implantable optical fibers for immunotherapeutics delivery and tumor impedance measurement.Nat. Commun.12, 5138 (2021)..

Ding, Y. P. et al. Electrospun fibrous architectures for drug delivery, tissue engineering and cancer therapy.Adv. Funct. Mater.29, 1802852 (2019)..

Talebian, S. et al. Biopolymers for antitumor implantable drug delivery systems: recent advances and future outlook.Adv. Mater.30, 1706665 (2018)..

Zhu, Y. J. et al. Rational design of biomaterials to potentiate cancer thermal therapy.Chem. Rev.123, 7326–7378 (2023)..

Mehrjou, B. et al. Design and properties of antimicrobial biomaterials surfaces.Adv. Healthc. Mater.12, 2202073 (2023)..

Ran, Y. et al. Fiber-optic theranostics (FOT): interstitial fiber-optic needles for cancer sensing and therapy.Adv. Sci.9, 2200456 (2022)..

Zhang, Y. K. et al. Rare earth-doped microfiber bragg grating refractive index sensor with self-photothermal manipulation.IEEE Photonics J.13, 6800309 (2021)..

Gourisankar, S. et al. Rewiring cancer drivers to activate apoptosis.Nature620, 417–425 (2023)..

Nelson, B. J.&Pané, S. Delivering drugs with microrobots.Science382, 1120–1122 (2023)..

Qiu, M. et al. Novel concept of the smart NIR-light–controlled drug release of black phosphorus nanostructure for cancer therapy.Proc. Natl Acad. Sci. USA115, 501–506 (2018)..

Yang, K. et al. Low temperature photothermal therapy: advances and perspectives.Coord. Chem. Rev.454, 214330 (2022)..

Yi, X. L., Duan, Q. Y.&Wu, F. G. Low-temperature photothermal therapy: strategies and applications.Research2021, 9816594 (2021)..

Zhao, R. B. et al. A drug-free tumor therapy strategy: cancer-cell-targeting calcification.Angew. Chem. Int. Ed.55, 5225–5229 (2016)..

Llovet, J. M. et al. Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma.Nat. Rev. Gastroenterol. Hepatol.18, 293–313 (2021)..

Gabizon, A. et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes.Cancer Res.54, 987–992 (1994)..

Masciocchi, C. et al. Uterine fibroid therapy using interventional radiology mini-invasive treatments: current perspective.Med. Oncol.34, 52 (2017)..

Song, Q. L. et al. An oral drug delivery system with programmed drug release and imaging properties for orthotopic colon cancer therapy.Nanoscale11, 15958–15970 (2019)..

Zhu, J. M. et al. EngineeredLactococcus lactissecreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy.Nat. Commun.13, 7466 (2022)..

Cabibbo, G. et al. Multimodal approaches to the treatment of hepatocellular carcinoma.Nat. Rev. Gastroenterol. Hepatol.6, 159–169 (2009)..

Liu, Y. et al. Near-infrared radiation-assisted drug delivery nanoplatform to realize blood–brain barrier crossing and protection for parkinsonian therapy.ACS Appl. Mater. Interfaces13, 37746–37760 (2021)..

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

⁰